Voiding Dysfunction
Saturday, May 16
IP33-01: Novel Non-Invasive Urodynamic System Based on Hyper Electrophysiological Mapping: Prospective Comparative Study with Conventional Urodynamics
IP33-02: Detrusor Pressure Estimation Enables Urodynamics Without Abdominal Pressure Measurement
IP33-03: CLINICAL VALIDATION OF WIRELESS CATHETER-FREE AMBULATORY URODYNAMICS IN MALE PATIENTS
IP33-04: Evaluation of ChatGPT-5 Reliability in Urodynamic Study Interpretation
IP33-05: When the heart wakes you up at night: insights from invasive hemodynamic assessment
IP33-06: Sex-specific cardiovascular and metabolic correlates of nocturnal polyuria: findings from the EpiNP study
IP33-07: Development and clinical utility of the sodium excretion shift index: A two-spot urine approach to evaluate nocturnal polyuria
IP33-08: Population-Based Assessment of Lower Urinary Tract Symptoms and Their Impact on Quality of Life in Mexican Adults: Results from the RegioLUTS Study
IP33-09: Patient-reported Lower Urinary Tract symptoms IN inflammatory bowel disease versus cOntrols: the PLUTINO study
IP33-10: Integrative Transcriptomic and Proteomic Analysis Reveals TGFB1-Driven Fibrotic Activation and PPARA-Mediated Metabolic Suppression in a Rat Model of Bladder Outlet Obstruction
IP33-11: Impact of continuous bladder drainage on bladder function in patients with detrusor underactivity: A urodynamic-based retrospective study
IP33-12: Intermittent Self-Catheterization in Male Patients with BOO and AUR Might Reintroduce Spontaneous Micturition Outcomes from a Prospective Study
IP33-13: Suprapubic Catheter Placement Improves Quality of Life: a Multi-Institutional Collaborative Project from the Society of Urodynamics, Female Urology, and Urogenital Reconstruction Research Network (SURN)
IP33-14: EJACULATION-PRESERVING TRANSURETHRAL INCISION OF THE PROSTATE: SAFETY AND OUTCOMES OF A NOVEL SURGICAL APPROACH FOR PRESERVING ANTEGRADE EJACULATION
IP33-15: Effects of tamsulosin 0.2mg or terazosin 5mg administration on post micturition dribbling (PMD) in men with lower urinary tract symptoms: A Prospective, open-label, Efficacy-evaluation Study
IP33-16: Safety and Efficacy of Bladder Outlet Procedures Prior to Prostate Radiation Therapy
IP33-17: HEALTH Randomized Trial – HIIT versus CME Effects on LUTS
IP33-18: Nocturnal Bladder Capacity Index Assessment to Improve Nocturia Management in Patients with Lower Urinary TractSymptoms Related to Benign Prostatic Hyperplasia
IP33-19: TGFB1 as a target regulator for ameliorating bladder outlet obstruction–induced bladder dysfunction in rats as revealed by Ingenuity Pathway Analysis
IP33-20: From blood sugar to bladder health: GLP-1 receptor agonists are associated with lower urinary complication risk in diabetes
IP33-21: Injection of human umbilical cord mesenchymal stem cells alleviates bladder outlet obstruction–induced detrusor underactivity through recruitment of resident bladder stem cells: Insights from single-nucleus RNA sequencing
IP33-22: Diagnostic Clues for Low-Pressure Female Bladder Outlet Obstruction Missed by Conventional Urodynamics
IP33-23: Radiologic Sarcopenia Is Associated With Reduced Bladder Contractility in Middle-Aged Women.
IP33-24: Sarcopenia Does Not Imply Underactive Bladder: Findings from a Community-Based Study
IP33-26: Clinical relevance of urinary microRNA miR-1273g-3p as a non-invasive biomarker for underactive bladder
IP33-27: Sex-Specific Patterns of Lower Urinary Tract Dysfunction Following Vincristine Chemotherapy
IP33-28: A multi-disciplinary approach to managing ketamine uropathy
IP33-29: Beyond dry eyes: Associations with urinary and renal morbidity in Sjögren’s syndrome
IP33-30: Overcoming Detrusor Underactivity: Functional Recovery After HoLEP in Real-World Practice
Registered attendees
Amy Dobberfuhl
Assistant Professor of UrologyStanford University